Navigation Links
again in Medical Technology

DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME

ATLANTA, Sept. 24 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that after completing its review of safety and efficacy data curre...

DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME

ATLANTA, March 24 /PRNewswire/ -- After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME(TM) (Fluocinolone Acetonid...

Infant Formula Manufacturers Again under Ethical Cloud: 'Marketing Gimmick' Linked to Serious Illnesses

ARLINGTON, Va., Jan. 25 /PRNewswire-USNewswire/ -- A report released today by The Cornucopia Institute presents research indicating that new additives placed in infant formula are seriously endangering the health of some formula-fed newborns and toddlers. The report, 'Replacing Mother--Imi...

Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma

Adding MabThera to first line chemotherapy significantly increases patients_ overall survival BASEL, Switzerland (21 May, 2007) _ In a study published yesterday in the Journal of Clinical Oncology, MabThera (rituximab) plus chemotherapy (MCP*) was shown to significantly improve survival in patie...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...osteoporosis has more than an 8 out of 10 greater chance of breaking another bone(12) One in four women who have broken a bone will fracture again within a year(13) Half of the women who break a hip will permanently need assistance to walk(14) Nearly one in four women who hav...

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...957 which revolutionized the way women cared for their skin by providing the first alternative to soap that was less drying to skin. Now, Dove is once again bringing category-changing technology to the personal wash category. "For over fifty years, Dove has led innovations in the skin care industry ...

New Review on PROSTVAC(TM) Published by Key Investigators From NCI

... disease characteristics." Anders Hedegaard, President & CEO of Bavarian Nordic said: "We are very pleased that the scientific experts once again confirm their positive view on PROSTVAC(TM) and the potential use of the vaccine in earlier stages of the disease. We are looking forward to publish m...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

...ics, clinical data and health-related quality of life data were collected at baseline. Clinical and health-related quality of life data were collected again at weeks eight and sixteen(3). Tadalafil increased 6MWD in a dose-dependent manner, only the 40 mg dose met the pre-specified level of statisti...

Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)

...r in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin-, macrolide-, and fluoroquinolone-resistant bacteria. Restanza's demonstrated poten...

Clinical Trial Results of Pollogen's TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology

...ovative TriPollar RF technology, developed by Pollogen, delivers consistent and effective results without pain and adverse side effects as proven once again by the leading scientists and labs in the world. Our customers worldwide are benefiting from the most advance RF technology bringing safe, effective s...

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

... should be considered." Ron Bentsur, Chief Executive Officer of Keryx, commented, "We believe that this single agent activity for perifosine once again demonstrates that perifosine is an active, novel agent with the potential to provide clinical benefit to patients with 2nd or 3rd line metastatic rena...

Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

...Influenza vaccines," stated Thomas Lingelbach, COO of Intercell AG and CEO of Intercell USA. "The recent H1N1 influenza situation certainly highlights again the important global public health need in this arena. If we achieve our goal to achieve full protection with only a single dose plus patch this means...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

...ed Cetor, a Dutch C1 inhibitor product, after the first two trimesters. An additional patient received Cinryze 1000U immediately prior to delivery and again two days later; Data on side effects, frequency of HAE attacks, and number of emergency medical visits prior to and following initiation of ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

.... for a postdoctoral associate position. In 2007, the NIH grant was renewed again for $1.25 million. "My life's ambition has been to identify a compound...ears I have had many drugs enter the clinic and then fail. And now I'm here again with another chance and I'm absolutely proud of our entire team. The only w...

Adding Steroid Drug to MS Treatment May Reduce Disease Activity

... also improved slightly on a test of MS disability, while the scores for the placebo group decreased slightly. At the beginning of the study and again after three years, the researchers measured the size of lesions in the brain that are a sign of disease activity. For those receiving both drugs, the ...

MedNet Solutions to Share Industry Expertise at the 13th Annual EDC & Beyond Conference in Orlando, FL

...Clinical Technologies for Optimal Synergistic Performance" panel discussion on Wednesday, April 29 at 4:15 p.m. MedNet solutions is proud to once again be a sponsor of the EDC & Beyond event, which brings together thought leaders from sponsor companies, CROs, investigative sites and e-clinical ser...

HeartWare International Clinical Trial Shows 90% Survival at 180 Days

...of adverse events were relatively low despite the unusually long average duration of pump support across the patient group. "These results appear again to confirm the benefits we believe to be inherent in the design of this device," said HeartWare CEO, Mr. Doug Godshall. "At the ISHLT meeting 12 mont...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

...e by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION(R) Coronary Stent System. Th...

Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

...mation we need to continue to move this program forward. While limitations were discovered in some of the new exploratory efficacy measures, elagolix again showed strong efficacy in the historical validated endometriosis measures, with an excellent safety profile." The Lilac PETAL study assessed endo...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

...e - the potential for systemic absorption of the drug at toxic levels and the need for pharmacokinetic (PK) testing to address that safety issue - OGD again turned away from patients with CDI. Instead, they concluded that PK testing is unnecessary because the drug is not absorbed in healthy patients who a...

Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain

...ays, study subjects applied Arthri-Zen Relief Cream(R) to joint "hot spots" three times a day. They were evaluated by a clinician on the first day and again on the tenth day for conditions such as arthritis, inflammation, swelling, joint stiffness, muscle pain and range of motion. Throughout the study, par...

March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots

...ortion to the concern. ("I can't face my book club tonight." "I wish I didn't have to leave the house and deal with anyone." "I hope I don't feel sick again today. What if I am?") Other symptoms include startling easily, trouble falling or staying asleep, difficulty concentrating, fatigue, muscle ten...

Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss

...test data gathered from one individual, a NKI employee who had undergone various I-Portal NOTC evaluations as part of routine product testing and then again after he suffered a bicycle accident last year. "The situation with our colleague presented us with a rare opportunity to evaluate a patient aft...

BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine

...ies of patents that it had previously licensed. Reiner Laus, MD, President & CEO of BN ImmunoTherapeutics, said: "I am pleased that we once again can confirm the unique safety profile of MVA-BN(R) and that we have been able to show immunogenicity in this patient group suffering from this severe ...

Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent

...e by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION(R) Coronary Stent System. The VI...

American Dairy Provides Business Update

... to provisions of the notes would terminate, interest would begin to accrue again and would be subject to increases if certain requirements are not met, and the holders would again have the right to convert the 2012 Notes into shares of common stock. ...

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

...tiple doses of SQ109 in healthy subjects. "This is absolutely the best of both worlds for Sequella," commented Dr. Carol Nacy, Sequella CEO. "We again successfully competed for support from our most valued funding partner, NIAID, while retaining the capacity to work with the same industry-leading con...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

...g filmmaker Joseph Lovett called "Blood Detectives," which will air on the Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unravel medical mysteries and save lives. ...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

...g filmmaker Joseph Lovett called "Blood Detectives," which will air on the Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unravel medical mysteries and save lives. ...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

...g filmmaker Joseph Lovett called "Blood Detectives," which will air on the Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unravel medical mysteries and save lives. ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

...Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unrave...Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unrave...

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

...g filmmaker Joseph Lovett called "Blood Detectives," which will air on the Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unravel medical mysteries and save lives. ...

Do You Know You're Having a Stroke?

...s, with the condition continually worsening. The thrombus or clot that is causing the stroke can frequently be dissolved or disintegrated so blood can again flow to the brain. In such cases, immediate treatment can mean the difference between a slight injury and a major disability. Interestingly only 20.8 ...

Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center

...to eliminate two drugs we initially used (steroids). On Mr. Hondusky, we are attempting to only use one drug as the initial treatment." "Once again this demonstrates the bravery of these pioneering men who are willingly to step into a procedure whose outcome is not fully known. Without these pion...

Texas Back Institute Leads Way in New Facet Joint Clinical Trial

... TBI is first and only participant in Texas for TFAS spinal implant PLANO, Texas, Nov. 6 /PRNewswire/ -- Texas Back Institute is leading the way again in motion preserving technology by continuing to advance spinal device studies with a clinical trial of the Total Facet Arthroplasty System (TFAS)(R)....

12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions

...and at 6-month follow-up. Further analysis of 1,904 cross sections (19,028 struts) by investigators using Optimal Coherence Tomography at baseline and again at 6-month follow-up in a subset of 15 randomly selected patients revealed complete endothelialization and 99.5 percent stent strut coverage. "Every...

Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting

...pe 2 diabetics," at the North American Association for the Study of Obesity (NAASO) Annual Meeting in Phoenix, Arizona. "We are pleased to have once again demonstrated the positive adverse event profile, good tolerability and predictable pharmacokinetics (PK) of MSI-1436, consistent with the results achi...

Clinical Study Results: Nutrition 21's Iceland Health(R) Chromax(R) Chromium Picolinate Reduces Hunger, Food Intake and Cravings

...) or matching placebo capsules for 8 weeks. Food intake was directly measured at the research center's eating laboratory at baseline, after 1 week and again after 8 weeks. Michael A. Zeher, president and chief executive officer of Nutrition 21, commented, "The results of this study provide substantial ev...

The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC

... Summary: Protein Tomography(TM) has yet again Provided Structural Proof of a Drug Target Function. A Study Performed by Sidec and UCB, Characterizes the Target of Anti-Epileptic Drug in Situ Wh...

Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks

... breast cancer for women. The Pakistani and Indian immigrant population in the United States also experiences rising rates of lung and colon cancer, again mirroring U.S. patterns. Immigrants have been shown to embrace the Western lifestyle of marrying later, having fewer children, getting less exercise...
Other Tags
(Date:11/4/2014)... death at the right time might actually help boost ... could help in understanding animal populations, pest control and ... in the journal Trends in Ecology and Evolution ... that the kind of positive population effect an overall ... depends on the size and developmental stage of the ...
(Date:11/4/2014)... Think about the way our bodies are assembled during ... that they are supposed to become a nerve or ... the correct place and alignment? Researchers at the University ... In a new study, UM researchers describe the signaling ... neighbors, at the head-trunk region. Their discovery may have ...
(Date:11/4/2014)... , November 4, 2014   ... market growth   Fuel3D , a developer ... a funding round totaling $6.4 million (£4 million). This funding ... secured earlier this year and paves the way for the ... The funding round was led by Chimera Partners ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
(Date:11/27/2014)... VogueQueen.com is making every effort to offer more affordable ... the premier online supplier of elegant special occasion dresses ... huge selection of sexy prom dresses today. In addition ... many beautiful styles in its product line. Click to ... , “VogueQueen.com hopes to provide a truly unique shopping ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 “LAB.C” was featured ... features the latest and coolest technology products available to consumers. ... the product review and shared with viewers the ... iOS and Android devices. , Consumers love portability and functionality. ... Their Cable Case for the iPhone5 and 5S has a ...
(Date:11/27/2014)... IN (PRWEB) November 27, 2014 Dr. Ronald ... clinic, has a few oral health tips before patients ... who offers Louisville and New Albany affordable cosmetic dentistry, ... foods high in starch and sugar. While the staff wishes ... some helpful tips for how patients can enjoy a feast ...
(Date:11/27/2014)... HealthPostures, a leading national ... has announced that it has entered into a ... partnership will put HealthPostures' products into central Indiana’s ... addition to having its products sold through Commercial ... products with the business decision makers in the ...
(Date:11/27/2014)... Allowing children to help with chores while they are ... responsibility, ownership, boosts self-esteem, and above all, helps parents maintain ... question is, how do you encourage your children to want ... published by Child Development Journal, there is. The study found ... child’s willingness to lend a hand. , The study ...
Breaking Medicine News(10 mins):Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
Other Contents